Skip to main content
Radcliffe Medical Education
Medical education learning resources for healthcare professionals
Radcliffe Medical Education banner
Radcliffe Medical Education banner
  • Home
  •  Tina Vilsbøll

Tina Vilsbøll 

Professor

Head of Clinic at Steno Diabetes Center, Copenhagen, Denmark

Biography

Tina Vilsbøll is a Clinical Professor and Head of Clinic at Steno Diabetes Center, Copenhagen, Denmark.

She has been involved in diabetes research since 1997 and in 2004 she established the Center for Diabetes Research at Gentofte Hospital, University of Copenhagen, Denmark, now part of Steno Diabetes Centre Copenhagen. Her research is focused on the pathophysiology of obesity, prediabetes, type 2 diabetes (with a specific focus on insulin, glucagon and incretin hormones), regulation of appetite and food intake, and the utilisation of incretins as therapeutics. Integration of the gut in the understanding of human glucose metabolism has become a major focus in her lab over recent years.

She has more than 300 scientific publications (H-index 64) and several published books and book chapters. Professor Vilsbøll is a frequently invited speaker at national and international meetings. Professor Vilsbøll is an experienced teacher and supervises several PhD and medical students conducting diabetes research.

In addition to her teaching and research posts, Professor Vilsbøll is a member of numerous professional societies and committees, and referees for several international journals. 

Featured Courses

The Rise of CVRM Medicine: Managing Common Co-morbidities as One
  • 3.00 EBAC

Learning objectives

  • Describe the link between T2DM, CKD and ASCVD
  • State the importance of early and effective intervention in managing CVRM disease progression
  • List the guideline directed therapeutic targets in CVRM disease
  • Select appropriate patients for holistic CVRM management
  • Recall trial data for novel therapeutic agents that carry benefit for CVRM outcomes
  • Develop a holistic management strategy for CVRM disease with an evidence-based impact on clinical outcomes
See more